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Vascular nicheSorting of native (unpermeabilized) SVF-cells from human subcutaneous (s)WAT for cell surface staining (cs)
of DLK1 and CD34 identiﬁed three main populations: ~10% stained cs-DLK1+/cs-CD34−, ~20% cs-DLK1+/
cs-CD34+dim and ~45% cs-DLK1−/cs-CD34+. FACS analysis after permeabilization showed that all these cells
stained positive for intracellular DLK1, while CD34was undetectable in cs-DLK1+/cs-CD34− cells. Permeabilized
cs-DLK1−/cs-CD34+ cellswere positive for the pericytemarkerα-SMA and themesenchymalmarkers CD90 and
CD105, albeit CD105 stainingwas dim (cs-DLK1−/cs-CD34+/CD90+/CD105+dim/α-SMA+/CD45−/CD31−). Only
these cells showed proliferative and adipogenic capacity. Cs-DLK1+/cs-CD34− and cs-DLK1+/cs-CD34+dim cells
were also α-SMA+ but expressed CD31, had a mixed hematopoietic and mesenchymal phenotype, and could
neither proliferate nor differentiate into adipocytes. Histological analysis of sWAT detected DLK1+/CD34+ and
DLK1+/CD90+ cells mainly in the outer ring of vessel-associated stroma and at capillaries. DLK1+/α-SMA+
cells were localized in the CD34− perivascular ring and in adventitial vascular stroma. All these DLK1+ cells
possess a spindle-shaped morphology with extremely long processes. DLK1+/CD34+ cells were also detected
in vessel endothelium. Additionally, we show that sWAT contains signiﬁcantly more DLK1+ cells than visceral
(v)WAT. We conclude that sWAT has more DKL1+ cells than vWAT and contains different DLK1/CD34 popula-
tions, and only cs-DLK1−/cs-CD34+/CD90+/CD105+dim/α-SMA+/CD45−/CD31− cells in the adventitial vascular
stroma exhibit proliferative and adipogenic capacity.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
White adipose tissue (WAT) is a major energy storage depot and en-
docrine gland (Gesta et al., 2007). Its physiological functions are mainly
fulﬁlled by adipocytes arising out of adipose-derived stromal/progenitor
cells (ASCs) (Yamamoto et al., 2007; Rodeheffer et al., 2008; Tang et al.,
2008), which constitute a large pool of adipocyte precursors crucial fordipocyte factor 1; MSC, mesen-
ite adipose tissue; CD117,mast/
it; CD105, endoglin; CD90, Thy-
cluster of differentiation 31 also
AM-1);α-SMA,α-smoothmus-
on microscopy.
Aging Research, University of
erschke).
. This is an open access article underadipose tissue homeostasis and expansion (Hausman et al., 2001; Berry
et al., 2013). Former studies implicating a predetermined number of fat
cells at birth were refuted. In fact, in adult humans ~10% of all fat cells
turnover each year (Spalding et al., 2008) and estimates indicate that
young adult mice generate ~15% of adipocytes each month (Rigamonti
et al., 2011). DifferentWAT depots, at subcutaneous (sWAT) and visceral
(vWAT) sites, comprise distinct adipocyte populations, which are gener-
ated by several processes during and after development. These fat cell
populations could arise from multiple germ layers and different
progenitor cell types (Majka et al., 2011). In fact, it was shown that
ASCs reside at the vascular interface and resemble mural cells that can
proliferate anddifferentiate into adipocytes (Tang et al., 2008).Moreover,
although controversially discussed, studies suggest that endothelial cells
and hematopoietic stem cells might give rise to a subset of adipocytes by
changing fate into mural cells and then converting to progenitors
(Crossno et al., 2006; Gupta et al., 2012; Medici et al., 2010; Sera et al.,
2009; Tran et al., 2012).the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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(SVF) of sWAT characterized ASCs by their plastic adherence in culture,
colony-forming capacity and the expression pattern of distinct cell sur-
face markers (Mitchell et al., 2006). These cells can promote angiogen-
esis (Rehman et al., 2004) and can be used as autologous ASCs for
regenerative therapy (Bourin et al., 2013). It has however not been
shown by rigorous assays that ASCs are capable of differentiating out-
side of their lineage into functional phenotypes without extensive mo-
lecular engineering, or extreme chemical treatment (like with BMP,
which will temporarily turn any ﬁbroblastic cell into an osteoblast-like
cell). The ASC population is broadly deﬁned by the International Society
for Cellular Therapy as a subset of cells positive for the mesenchymal
stem/stromal cell (MSC) markers CD90 and CD105 (Mitchell et al.,
2006), and the stem/progenitor cell marker CD34 (Sengenès et al.,
2005; Sidney et al., 2014), lacking the expression of the endothelial
marker CD31, summarized as CD34+/CD90+/CD105+/CD31− (Bourin
et al., 2013). There is, however, no consensus about the exact pattern
of markers being expressed by ASCs. No deﬁnitive singular marker to
precisely deﬁne ASCs in human adipose tissues is known and although
certain MSC markers are recommended, none are speciﬁc for a stem
cell of any type. They are expressed on virtually all ﬁbroblastic cells
that are not stem cells based on rigorous assays (Bianco et al., 2008). Ac-
cording to the current model, in human adipose tissue, vessel-Fig. 1. Detection of DLK1+/CD34+ cells in the SVF of human sWAT. A. (Upper left panel) Native (u
tein (staining with anti-DLK1 and anti-CD34 antibody without permeabilization and ﬁxation) by
protein (staining with anti-DLK1 and anti-CD34 antibody after ﬁxation and permeabilization) by
panel) Increasing staining intensity for DLK1 after permeabilization and ﬁxation of SVF cells is sho
(P4) SVF cell populations (upper panel)wereﬁxed, permeabilized and further analyzedby FACS foassociated stromal cells are organized in two layers, perivascular in an
inner ring and more peripheral in an outer ring (Zimmerlin et al.,
2013). ASCs reside in the outer adventitial layer encircling small vessels;
the spatial organization of ASCs in the vascular stroma of adipose tissues
is however not precisely understood.
Delta-like protein 1/preadipocyte factor 1 DLK1(PREF1) is an pater-
nally expressed imprinted gene that encodes a transmembrane protein
containing six epidermal growth factor-like repeats at the extracellular
domain, a juxtamembrane region with a TNF-alpha-converting enzyme
(TACE)-mediated cleavage site, a transmembrane domain and a short
intracellular region (Smas and Sul, 1993; Laborda et al., 1993). Upon
cleavage by the TACE protease, it can be released as a soluble protein
(Sul, 2009). DLK1 is a crucial regulator of ASC homeostasis in WAT.
Evidence was presented that DLK1 negatively regulates proliferation
(Mortensen et al., 2012) and terminal differentiation of adipocyte pro-
genitors into adipocytes and other mesenchymal lineages (Wang and
Sul, 2009). Studies on mouse models conﬁrm these inhibitory effects
of DLK1. Animals with increased levels of DLK1 show less total body
weight and a decrease in fat mass, whereas DLK1-null mice increases
fat mass (Villena et al., 2008; Abdallah et al., 2007; Lee et al., 2003;
Mortensen et al., 2012). DLK1 is implicated in stem/progenitor cell
biology during embryonic development and in several organs of adults
(Floridon et al., 2000; Sul, 2009; Abdallah and Kassem, 2012; Andersennpermeabilized) cells in the SVFwere analyzed for cell surface tethered DLK1 and CD34 pro-
FACS. (Upper middle panel) Cells in the SVF were analyzed for intracellular DLK1 and CD34
FACS. (Upper right panel) Staining of cells in the SVF with isotype control antibodies. (Lower
wn. B. The cs-DLK1+/cs-CD34− (P2), cs-DLK1+/cs-CD34+dim (P3) and cs-DLK1−/cs-CD34+
r the expression of themarker proteins CD90, CD105,α-SMA, CD31 andCD45 (lower panels).
Fig. 1 (continued).
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press DLK1 and its main role is most likely to regulate clonal expansion
and terminal adipogenesis (Sul, 2009; Traustadottir et al., 2013). There is
also evidence for a role of DLK1 in vascular endothelium of adipose tissue
(Andersen et al., 2009a). We recently showed that DLK1+/CD105+/
CD90+/CD34+/CD31− ASCs constitute amajor population in early passage
isolates fromthe SVFof human sWATand thatDLK1 regulates adipogenesis
in these cells (Mitterberger et al., 2012). The aim of the present communi-
cation was to further characterize DLK1+ ASCs in humanWAT.2. Materials and methods
2.1. Donors
Human adipose tissue samples were either removed from fresh
cadavers (n = 18) or taken from patients undergoing routine
abdominoplasty (n = 7) at the Institute for Plastic and Reconstructive
Surgery (Medical University Innsbruck). The patients gave their
informed written consent and had been approved by the ethical
406 M.E. Zwierzina et al. / Stem Cell Research 15 (2015) 403–418committee of Innsbruck Medical University, Austria, according to the
Declaration of Helsinki. Cadavers had been donated to the Department
of Anatomy. Due to immediate anonymization of the dead bodies no
certiﬁcate of non-objection was needed.
2.2. Sample collection
From the Department of Anatomy 15 female and three male
cadavers with a post-mortem interval from 4 to 24 h were included in
this study. The mean donor age was 85 years at the time of death
(range: 63–101 years), showing no apparent disorders in lipid metabo-
lism. Two patients were obese (BMI N30.0), two overweight (BMI 25.0–
30.0) and 14 had normal weight (BMI 18.5–25.0). Seven fresh tissue
samples from the plastic surgery were obtained from ﬁve non-obese,
healthy female donors and two male with a mean age of 42 years
(range: 28–51 years).
2.3. Cell culture and transfection
ASCs were isolated and cultivated as described (Mitterberger et al.,
2014b). Brieﬂy, after surgery adipose tissue biopsies were transferred
into sterile serum-free ASC medium (DMEM/F-12 medium (1:1) with
HEPES and L-glutamine (Gibco, Vienna, Austria), supplemented with
33 μM biotin, 17 μM pantothenate and 12.5 μg/ml gentamicin and
kept at 4 °C for 1–3 h before sterile processing). Fibrous material and
blood vessels were dissected. The tissue was cut and collagenase
digested. The cells of the stromal-vascular fraction (SVF) were enriched
by centrifugation and ﬁltration steps and erythrocyte lysis. The pellet-
ized SVF was suspended in ASC medium supplemented with 10% FBS
(Gibco, Vienna, Austria) and ﬁltered again. Aliquots of cells were inocu-
lated at a density of 70,000/cm2 into 6-well plates. After 16 h of cell
attachment, cells were washed with ASC medium and maintained for
6 days in ASC medium without FBS. The remaining cell population
was referred to as adipose-derived stromal/progenitor cells (ASCs).
For cultivation ASCs were seeded in a density of 5000 cells/cm2 in ASC
medium plus 10% FBS and maintained at 37 °C with 5% CO2. 16 h later
the medium was replaced by PM4 medium (ASC medium containing
2.5% FBS, 10 ng/ml EGF, 1 ng/ml bFGF, 500 ng/ml insulin). ASC were
passaged at a ratio of 1:2, medium was changed every third day and
the cells were grown to 70% conﬂuence before splitting. HeLa cells
(Kaiser et al., 2015) were cultured and transiently transfected with
pLenti-DLK1 (Mitterberger et al., 2012) and empty vector as described
(Mitterberger et al., 2014a).
2.4. FACS analysis
20 × 106 SVF cells were stained with anti-CD34 and anti-
DLK1(PREF-1) antibodies and sorted by FACSArIa (BD, Bioscience).
Purity of the sorted fractions was analyzed by FACS before functionalFig. 2. Functional characterization of cs-DLK1−/cs-CD34+, cs-DLK1+/cs-CD34− and cs-DLK1+/
abdomen of three different donors, protein concentration determined by BCA protein assay
using anti-DLK1 antibodies. HeLa cervical cancer cells transfected with empty vector (M
unpermeabilized SVF cells based on surface expression of CD34 and DLK1 were sorted by
cs-DLK1−/cs-CD34+, cs-DLK1+/cs-CD34− and cs-DLK1+/cs-CD34+dim cells. C. Protein lysates
buffer containing DTT and β-mercaptoethanol, protein concentration determined by BCA prote
blotting using anti-DLK1 antibodies. β-Actin served as input control. D. Analysis of DLK1 (left pan
and cs-DLK1+/cs-CD34+dim cells. mRNA expression wasmeasured relative to actin using q-RT-P
from the SVF. 1 × 105 sorted cells from different subsets were seeded in 12-well plates and pr
6 days after seeding are shown. F. Colony formation assay. (Left panel) 500 cells of each cell ty
The number of colonies formed from single cells after 10 days is indicated. G. Adipogenic diff
panel) Indicated cell types were subjected to the adipogenic differentiation protocol and diffe
counted, 39 +/− 3% of cs-DLK1−/CD34+ cells differentiated into adipocytes. (Lower panel) A
by analyzing the expression of the adipogenic key regulator PPARγ2 and of the adipocyte differe
levels were monitored by western blot analysis. For the mRNA expression analysis, the expressstudies. For surface stainings, cells were stained without ﬁxation while
cells were ﬁxed and permeabilized for intracellular stainings.
2.5. Proliferation assay
1 × 105 sorted cells from different subsets were seeded in 12-well
plates and proliferation of cells was monitored by counting and
photographing the cells.
2.6. Colony formation assay
The colony formation assay was done as described (Pochampally,
2008). Brieﬂy, 500 cells were seeded in six well plates as described
above. After 10 days of culture colonies derived from single cells were
ﬁxed, stained with crystal violet and counted.
2.7. Adipogenic differentiation assay
Sorted fractions were seeded in a 12-well plate at a concentration of
35,000/cm2 and adipogenesis induced as described (Mitterberger et al.,
2012). Adipogenesis was evaluated by analysis of the mRNA expression
levels of PPARγ2, FABP4 and Perilipin, and staining the cells with Oil-
red-O at day 18 of adipogenesis.
2.8. Cell clots
See supplemental information.






2.12. Image analysis of immunohistochemistry
See supplemental information.
2.13. Immunoﬂuorescence experiments on parafﬁn sections
See supplemental information.cs-CD34+dim cells. A. Protein lysates were prepared from sWAT obtained from the lower
and equal amounts of protein separated by SDS PAGE and analyzed by western blotting
ock) and a DLK1 overexpression vector (DLK1 OV) served as controls. B. Subsets of
FACS and purity of the sorted fraction was analyzed. Three populations were isolated,
from cs-DLK1+/cs-CD34− and cs-DLK1+/cs-CD34+dim cells were prepared in SDS sample
in assay. Equal amounts of protein were separated by SDS PAGE and analyzed by western
el) and CD34mRNA expression (right panel) in cs-DLK1−/cs-CD34+, cs-DLK1+/cs-CD34−
CR analysis (n = 4). E. Proliferative capacity of the different DLK1/CD34 cell types isolated
oliferation of cells was monitored by cell counting for 7 days. Representative Photographs
pe were seeded, cultured for 10 days, ﬁxed and stained with crystal violet. (Right panel)
erentiation capacity of the different DLK1/CD34 cell types isolated from the SVF. (Upper
rentiated cells were detected by Oil-red-O staining and light microscopy. 400 cells were
dipogenic differentiation in the cs-DLK1−/CD34+ cells was also monitored by q-RT PCR
ntiation markers FABP4 and Perilipin at day 21 post induction. Moreover, Perilipin protein
ion level at day 0 was deﬁned to be 1. Error bars= S.E.M., n = 4.
407M.E. Zwierzina et al. / Stem Cell Research 15 (2015) 403–4182.14. Image analysis of immunoﬂuorescence
See supplemental information.2.15. Preembedding immunoperoxidase stainings for light and transmission
electron microscopy (TEM)
See supplemental information.2.16. Image analysis of preembedding immunoperoxidase stainings on
TEM level
See supplemental information.2.17. Western blot analysis
See supplemental information.
Fig. 2 (continued).
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Q-RT PCR analysis was conducted as described (Lechner et al., 2013).
See supplemental information for the primer list.
2.19. Comparison of DLK1+ cells in sWAT and vWAT and statistical analysis
See supplemental information.
3. Results
3.1. Characterization of DLK1+/CD34+ cells in the SVF of human sWAT
To better understand the importance of DLK1 for ASCs we sorted
native (unpermeabilized) SVF cells from sWAT for cell surface staining
(cs) of DLK1 and CD34 (Fig. 1A). This approach identiﬁed three different
cell populations: 10.1% of all SVF cells were cs-DLK1+/cs-CD34−
(population, P2), 19.8% were cs-DLK1+/cs-CD34+dim (P3) and 43.4%
stained cs-DLK1−/cs-CD34+ (P4) (Fig. 1A, upper left panel). Analysis
of permeabilized SVF cells revealed strong intracellular staining for
DLK1 in P4 cells (Fig. 1A, upper middle panel and lower panel). As ex-
pected, the DLK1 staining intensity of P2 and P3 cells also increased, in-
dicating that all three populations contain intracellularDLK1protein.No
intracellular staining for CD34was detected in P2 (Fig. 1A, uppermiddle
panel). The SVF contains CD90+ (data not shown) and CD105+dim cells
(Supplemental Fig. 1). Further FACS analysis of permeabilized cells
showed that cs-DLK1−/cs-CD34+ cells (P4) (Fig. 1B, upper panel),
expressed the two mesenchymal marker proteins (CD90+ and
CD105+dim) (Fig. 1B, lower right panels), albeit CD105 staining intensity
in SVF cells was relatively low. The CD105 level increased during in vitro
expansion (Supplemental Fig. 1). These cells stained also positive for the
pericyte marker α-smooth muscle actin (α-SMA) but expressed neither
the hematopoietic lineage marker protein CD45 nor the endothelial
cell marker protein CD31 (Fig. 1B, lower right panels). Thus, we
nomenclatured these cells in the SVF as cs-DLK1−/cs-CD34+/CD90+/
CD105+dim/α-SMA+/CD45−/CD31− ASCs. The two populations with
cell surface-tethered DLK1 protein (Fig. 1B, upper panel), which co-
expressed either no CD34 (cs-DLK1+/cs-CD34−) (P2) or low levels of
CD34 on the surface (cs-DLK1+/cs-CD34+dim) (P3), stained also positive
for α-SMA but differed in the expression of the other marker proteins
(Fig. 1B, lower left andmiddle panels). Cs-DLK1+/cs-CD34− cells stained
positive for CD45, CD90 and dimly positive for CD105 (Fig. 1B, lower left
panels). Cs-DLK1+/cs-CD34+dim cellswere negative for CD45 andCD105
but positive for CD90 (Fig. 1B, lower middle panels). We conclude,
cs-DLK1+ cells express mesenchymal, pericyte and hematopoietic
markers and no or low levels of CD34. Interestingly, both cs-DLK1+ cell
populations were positive for the endothelial marker CD31 (Fig. 1B,
lower left and middle panels), comprising the immune phenotypes
cs-DLK1+/cs-CD34−/CD90+/CD105+dim/ α-SMA+/CD45+/CD31+
and cs-DLK1+/cs-CD34+dim/CD90+/CD105−/α-SMA+/CD45−/CD31+.
Thus only the large SVF fraction of cs-DLK1−/cs-CD34+/CD90+/
CD105+dim/ α-SMA+/CD45−/CD31− cells possessed a mesenchymal
and pericyte-like phenotype. The other two cell populations showed
mixed expression of mesenchymal, pericyte, hematopoietic and endo-
thelial markers.
3.2. Cs-DLK1−/cs-CD34+ cells but neither cs-DLK1+/cs-CD34− nor
cs-DLK1+/cs-CD34+dim cells undergo clonal expansion and terminal
adipogenic differentiation
Multiple isoforms of DLK1 are described, due to posttranslational
modiﬁcations and alternative splicing. The abundance of these isoforms
varies depending on tissue and cell type (da Rocha et al., 2009; Ferrón
et al., 2011; Lee et al., 1995; Mei et al., 2002; Mortensen et al., 2012;
Smas et al., 1994; Sul, 2009). We show that in human sWAT the
55 kDa and a ~40 kDa DLK isoforms are most abundant (Fig. 2A).Next we isolated the cs-DLK1−/cs-CD34+, cs-DLK1+/cs-CD34− and
cs-DLK1+/cs-CD34+dim cell populations by FACS sorting of native cells
from the human SVF (Fig. 2B) and compared DLK1 protein isoforms
and abundance in cs-DLK1−/cs-CD34+ and cs-DLK1+/cs-CD34+dim
cells. DLK1 protein was detected in both cs-DLK1+ as well as in
cs-DLK1− cells (Fig. 2C). The overall DLK1 protein levels in cs-DLK1+
cells were howevermuch higher than in cs-DLK1− ASCs andwe detect-
ed different DLK1 isoformpattern in the given cell types. The level of the
55 kDa DLK1 isoform was higher in cs-DLK1− ASCs than in cs-DLK1+
ASCs, while a 50 kDa isoformwasmore abundant in cs-DLK1+ cells. In-
triguingly, a highly abundant large isoform of the DLK1 protein
(~110 kDa) was detected in cs-DLK1+ cells but not in cs-DLK1− ASCs
(Fig. 2C). Since SDS-PAGE/western blot was done in reducing condi-
tions, this band results most likely not from dimer formation by disul-
ﬁde bridges although the DLK1 protein contains multiple cysteine
residues. Moreover, some faint DLK1 protein bands between 35 and
40kDa and a ~20 kdaband could only be detected in cs-DLK1+cells. Inter-
estingly, we found that the DLK1mRNA expression levels in the given ASC
subtypes did not correlatewithDLK1protein levels, as demonstrated by q-
RT PCR analysis (Fig. 2D). This underscores that the DLK1 protein levels in
human ASCs are regulated at the post transcriptional level. In fact, DLK1
mRNA expression was approximately 40 times higher in cs-DLK1−/
cs-CD34+ cells than in cs-DLK1+/cs-CD34− or cs-DLK1+/cs-CD34+dim
cells, which contain high level of cell surface bound DLK1 protein. This
suggests that the turnover of DLK1 protein in cs-DLK1−/cs-CD34+
ASCs is higher. As expected CD34 mRNA expression was strongly up-
regulated in cs-DLK1−/cs-CD34+ cells relative to cs-DLK1+/cs-CD34−
ASCs. These data corroborate that the given cell types express DLK1
and CD34.
We analyzed the proliferative and adipogenic capacity of the differ-
ent DLK1/CD34 cell populations isolated by sorting of native cells from
the human SVF (Fig. 2B). Interestingly, we found that only cs-DLK1−/
cs-CD34+ (P4) cells showed strong proliferation (Fig. 2E and F) and
high terminal adipogenic differentiation capacity (Fig. 2G), while
cs-DLK1+/cs-CD34− (P2) and cs-DLK1+/cs-CD34+dim (P3) cells could
neither proliferate (Fig. 2E and F) nor differentiate into adipocytes
(Fig. 2G). Together our data suggest that only SVF cells without cell
surface-tethered DLK1, but with cell surface-bound CD34, can under-
go clonal expansion and terminal adipogenesis, while cell surface-
tethered DLK1 has inhibitory effects. Similarly, a previous study by
Mortensen et al. (2012) showed that only non-cleavable cell surface-
tethered DLK1 isoforms inhibit 3T3-L1 preadipocyte proliferation.
While this supports the model that adipose tissue expansion occurs
through proliferation and terminal adipogenic differentiation of
preadipocytes, future studies are necessary to better understand the
nature and role of the different DLK1 isoforms in human ASCs.
3.3. Localization of DLK1+/CD34+ cells in intact human sWAT
We characterized the spatial organization of DLK1+ ASCs in intact
human sWAT by immunohistochemistry (IHC) using amousemonoclo-
nal anti-DLK1 antibody (Supplemental Fig. 2A and B). This antibody
detected the majority of DLK1+ cells in the outer adventitial ring
associated with vascular stroma and around capillaries (Fig. 3A and B).
A signiﬁcant number of cells in the endothelial layers lining small ves-
sels stained also positive for DLK1 (Fig. 3C, left and right panel). More-
over, DLK1+ cells were less frequently located in close proximity to fat
cells (Fig. 3D). The morphology of DLK1+ cells was studied using native
aswell as pre-embedding transmission electronmicroscopy (TEM). The
ultra-structural analyses demonstrated that DLK1+ cells were charac-
terized by a spindle-shape and extremely long cytoplasmic processes
(Fig. 3E–H). According to their location and morphology, these cells
could also be natively identiﬁed (Fig. 3I). CD34+ cells were abundantly
found in the outer adventitial ring associated with vascular stroma and
around capillaries (Fig. 3J–M). In addition CD34+ cells were detected in
many but not all endothelial layers lining small vessels (Fig. 3J). Some
410 M.E. Zwierzina et al. / Stem Cell Research 15 (2015) 403–418CD34+ cells were located in close proximity to fat cells (Fig. 3N). Single
staining using indirect immunoﬂuorescence and a confocal laser scan-
ning system detected also DLK1+ (Fig. 4A–C, arrow heads) and CD34+(Fig. 4D–F) cells in the vascular stroma and in the endothelial layer of
small vessels of sWAT, corroborating our IHC results. Additional CD31
staining was conducted to visualize the endothelium (Figs. 3O–Q
411M.E. Zwierzina et al. / Stem Cell Research 15 (2015) 403–418and 4G–I). Co-stainings mainly detected cells positive for both CD34
and DLK1 in the outer adventitial ring associated with vascular stroma
and around capillaries (Fig. 3R, black asterisks, black arrow heads ininserts). CD34+/DLK1+ double-positive cells were also detected in
endothelial layers of small vessels (Fig. 3R, upper panels, white as-
terisks, black arrow heads in inserts). These data complement the
Fig. 3. Detection of DLK1+ and CD34+ cells in intact human sWAT. A. IHC staining of sWAT parafﬁn sections using antibodies against DLK1. DLK1+ cells surrounding vessels and next to
capillaries are shown. Arrow headmarks the cell next to a capillary. Inset shows DLK1+ cells in highermagniﬁcation. Asterisk indicates the localization of the inserts. V, vessel, C, capillary.
Bar: 50 μm. Inset: 10 μm. B. Light microscope micrograph of a semi-thin sWAT section. Location of DLK1+ cells around small vessels in sWAT (arrow heads). V, vessel. Bar: 25 μm. C. IHC
stainings of cells in the inner endothelial ring of blood vessels in sWAT using antibodies against DLK1. V, vessel. Bar: right panel 50 μmand left panel 20 μm. Inset: 5 μm.D. Lightmicroscope
micrograph of a semi-thin sWAT section. Location of DLK1+ cells around small vessels andmore peripherally between fat cells are shown (arrowheads). V, vessel, F, fat cell. Bar: 25 μm. E–I.
Morphologyof DLK1+ASCs in fresh sWAT. Pre-embedding electronmicroscopyonultra-thin sections showsDLK1+ cells (arrowheads), located in the adventitial region of the vasculature
(E–G) ormore peripherally (H). Note the long cytoplasmatic processes of these cells. V, vessel, E, endothelial cell, ASC, adipose-derived stromal/progenitor cell, SMC, smoothmuscle cell, F,
fat cell. (I) Native electronmicrocopy. L, lumen, E, endothelial cell, SMC, smoothmuscle cell, ASC, adipose-derived stromal/progenitor cell. Bar: E–G (5 μm), H (2 μm), I (1 μm). J. IHC stain-
ing of sWATparafﬁn sections using antibodies against CD34. CD34+ cells surrounding vessels and next to capillaries are shown. Inset shows CD34+endothelial cells (arrowhead) inhigher
magniﬁcation. Asterisk indicates the localization of the insert. V, vessel. Bar: 50 μm. Inset: 10 μm. K. Light microscope micrograph of a semi-thin sWAT section. Location of CD34+ cells
around small vessels in sWAT is shown (arrow heads). V, vessel. Bar: 25 μm. L. Light microscopemicrograph of a semi-thin sWAT section. CD34+ cells (arrow heads) are present around
vessels. V, vessels. Bar: 25 μm.M. Pre-embedding electronmicroscopy showing the location andmorphology of CD34+ cells (arrow heads) in the outer adventitial ring of small blood ves-
sels. E, endothelial cells, V, vessel, SMC, smoothmuscle cell. Bar: 10 μm. N. Lightmicroscopemicrograph of a semi-thin sWAT section. A CD34+ cell (arrow head) presentmore peripherally
between fat cells is shown. F, fat cell. Bar: 25 μm. O. IHC staining of endothelial cells marking the inner ring of small blood vessels and capillaries in human sWAT sections by an anti-CD31
antibody. V, vessel, C, capillary. Bar: 50 μm. P. Vessels (arrow heads) are shown in a semi-thin section of WAT. Asterisk indicates the localization of the insert. Note that endothelium cells
are CD31 positive. V, vessel. Bar: 50 μm. Insert: 5 μm. Q. Pre-embedding electronmicroscopymarking the endothelium (arrowheads) of small blood vessels. V, vessel, SMC, smoothmuscle
cell. Bar: 5 μm. R. Double-staining IHCs for DLK1 (brown) and CD34 (red). Inserts show stromal cells co-containing both DLK1 and CD34 protein (arrow heads). Asterisks indicate the
localization of the inserts. DLK1+/CD34+ double positive cells were also detected in the endothelial layers lining the small vessels (V), indicated by arrows. Bar: 25 μm. Insert: 10 μm.
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CD31− and DLK1+/CD34+dim/CD31+ cells in the SVF (Fig. 1B). Although
the IHC analysis is not quantitative the histological data suggest thatDLK1+ cells copy the same location and morphology as CD34+ cells in
the outer adventitial ring, around capillaries and in vascular endothelia
of intact sWAT.
Fig. 4. Detection of DLK1, CD34, CD31 and α-SMA positive cells in human sWAT using indirect immunoﬂuorescence and a confocal laser scanning system. Detection of DLK1 (A–C, arrow
heads), CD34 (D–F), CD31 (G–I), and α-SMA (J–L) in sWAT. Positive cells (green) are shown in relation to their location to vasculature in sWAT. TO-PRO-3 (nuclei) (red). Bar: A–L (25 μm).
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positive for mesenchymal and hematopoietic lineage marker proteins.
To make precise comparison of the same cells stained for CD90 and
DLK1 proteins, two consecutive “mirror” sections were stained by IHC,
which allows separate staining of the same section surface by two dif-
ferent antibodies (Nakamura et al, 1999). This procedure demonstrateda high abundance of DLK1+/CD90+ cells in stroma surrounding small
vessels and around capillaries (Fig. 5A). In fact, the majority of DLK1+
cells were co-stained with the mesenchymal marker CD90. Co-staining
of DLK1 with the hematopoietic lineage marker CD45 (Fig. 5B) and the
hematopoietic stem cell marker CD117(c-Kit) (Fig. 5C) led to the detec-
tion of DLK1+/CD45+ and DLK1+/CD117+ double-positive cells in
414 M.E. Zwierzina et al. / Stem Cell Research 15 (2015) 403–418intact sWAT, which were however much less abundant than DLK1+/
CD90+ cells and only sporadically distributed throughout the adipose
tissue.To analyze whether DLK1+ cells show pericyte features we
employed α-SMA antibodies. α-SMA+ cells were mainly located
perivascular next to the endothelium and to a lesser extent more
Fig. 5. Co-staining of DLK1+ cells with CD90, CD45, CD117, andα-SMA in intact human sWAT. A: Consecutive “mirror” sections of human sWAT using antibodies against CD90 (left panel
and arrowhead) andDLK1 (right panel and arrowhead) demonstrates localization of both proteins in the same cell. Asterisks indicate the localization of the inserts. B and C:Double-stain-
ing IHCs for DLK1 (brown)/CD45 (red) and DLK1 (brown)/CD117 (red) showing cells double-positive for both markers (arrow head). Asterisks indicate the localization of the inserts. D:
IHC stainings demonstrate α-SMA positive cells around blood vessels. Inserts show α-SMA positive cells in the adventitial ring (white arrow heads) and pericytes (black arrow head).
Asterisk indicates the localization of the insert. E: Pericytes/smooth muscle cells (arrow heads) are shown in a semi-thin section of WAT. Inset showing the location of α-SMA positive
cells next to an endothelial cell. Asterisk indicates the localization of the insert. Section was not counterstained with toluidine blue. F: Pre-embedding electron microscopy marking
α-SMA positive cells (arrow heads) and their location around small blood vessels/capillaries. V, vessel, E, endothelial cell, SMC, smooth muscle cell. G: Double-staining IHC showing
DLK1+/α-SMA+ pericytes (arrow heads) and DLK1+/α-SMA+ cells located more peripherally in the adventitial ring (arrows). Asterisks indicate the localization of the inserts. Bar: A
and B (50 μm), C, D, E and G (25 μm), F (3 μm), Inset: D (15 μm), A, B and G (10 μm), and C and E (5 μm).
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embedding techniques corroborated these ﬁndings, cells positive for
α-SMA were mainly located perivascular (Fig. 5E and F). Co-staining
with anti-α-SMA and anti-DLK1 antibodies detected DLK1+/α-SMA+
cells perivascular in the inner ring of vessel-associated stromal cells
(Fig. 5G, arrow heads) but also in the outer adventitial ring, relative
close to theperivascular ring (Fig. 5G, rightpanel, arrows). Thesedata suggest
a high abundance of DLK1+/α-SMA+ cells in the vessel stroma of intact
sWAT and complement our FACS analysis, which indicated that the cs-
DLK1−/cs-CD34+/CD31− cell population in the SVF is α-SMA+ (see below,
Fig. 1B). Moreover, the FACS analysis detected cs-DLK1+/cs-CD34−/α-
SMA+/CD31+ cells in the SVF, which would be congruent with our IHC de-
tection of DLK1+/α-SMA+ cells in the CD34− perivascular ring.
3.4. Visceral WAT depots contain less DLK1+ cells than subcutaneous
WAT depots
DLK1 expression in human vWAT depots is unknown. To address this
question, we stained parafﬁn sections of different vWAT and sWAT depots
derived from 10 donors using anti DLK1 antibodies and compared the num-
ber of DLK1+ cells (Fig. 6A–D).We found that the numbers of DLK1+ cells in
omental, perirenal and pericardial vWAT depots were signiﬁcantly lower
than in sWAT depots (lower abdomen, thigh and breast) (6 F), although
DLK1+ cells could be sporadically detected around capillaries and small ves-
sels in all vWAT depots. Consecutive sections from the omental vWAT depot
stained by DLK1 (Fig. 6A) and CD34 (Fig. 6E) demonstrated that only the
number of DLK1+ cells was reduced in the visceral fat depot however not
the number of CD34+ cells.
4. Discussion
Renewal of adipose tissue from progenitor cells is important for its
homeostasis throughout life. DLK1-positive adipose precursors among
others are required for adipose tissue expansion in adult mice Hudak
et al. (2014). The mechanisms regulating expansion of the adipogenic
lineage and terminal adipogenesis are however little understood,
especially in human adipose tissues. In the present study, we demon-
strated for the ﬁrst time that the SVF of human sWAT contains three
different cell populations deﬁned by DLK1 and CD34. Only cs-DLK1−/
cs-CD34+/CD90+/CD105+dim/α-SMA+/CD45−/CD31− cells showed
high proliferative and adipogenic capacity. Cs-DLK1+/cs-CD34− andcs-DLK1+/cs-CD34+dim cells, which bear cell-surface-tethered DLK1,
consistently co-expressedα-SMA and CD31 and had amixed hematopoi-
etic and mesenchymal phenotype, could neither undergo proliferation
nor terminal adipogenesis. While previous studies underscore that DLK1
restricts adipose tissue size by inhibiting clonal expansion and terminal
adipogenesis of ASCs (Sul, 2009; Traustadottir et al., 2013), our data sug-
gest that cell surface expression of DLK1 plays a role in the regulation of
clonal expansion and terminal adipogenesis of human ASCs. Further
work is necessary to elucidate the role of intracellular DLK1.
To histologically characterize DLK1+ cells in the vascular stroma of
intact human sWAT we combined DLK1 in situ staining with stainings
of different stem/progenitor and lineage marker proteins. According to
the current model, human ASCs are positive for the stem/progenitor
cell marker CD34+ and mainly localized in the adventitia of small ves-
sels (Sengenès et al., 2007; Zimmerlin et al., 2013). In the present
study, we corroborate these data, demonstrate for the ﬁrst time a high
abundance of DLK1+/CD34+ cells in the SVF derived from human
sWAT and show localization of those cells in the outer adventitial stro-
mal ring of small vessels and at capillaries. The vast majority of DLK1+
cells localized in this region stained also positive for CD90, indicating
the mesenchymal character of the DLK1+/CD34+ cells.
Interestingly, we detected DLK1+/α-SMA+ cells perivascular and in
the outer adventitial stromal ring. α-SMAmarks pericytes and vascular
smoothmuscle cells, also referred to asmural cells, which residemainly
perivascular (Cai et al., 2011; Corselli et al., 2012; Lin et al., 2008;
Maumus et al., 2011). Increasing evidence suggest that CD34+ ASCs in
the vascular stroma, which are required for adipose tissuemaintenance,
arise from aα-SMA+mural lineage (Tang et al., 2008; Jiang et al., 2014;
Zimmerlin et al., 2013). Our IHC results show that DLK1+/α-SMA+ cells
are localized in the CD34− perivascular inner ring of vessel-associated
stroma. This matches with the detection of cs-DLK1+/cs-CD34−/α-
SMA+ SVF cells by FACS analysis. IHC analysis detected also DLK1+/α-
SMA+ cells at the interphase between perivascular ring and adventitia
and in the adventitial vascular stroma, which is in accordance with the
detection of cs-DLK1−/cs-CD34+/α-SMA+ SVF cells by FACS analysis.
Thus, it is conceivable that such cells emerge during transition from a
cs-DLK1+/cs-CD34−/α-SMA+ pericyte lineage to cs-DLK1−/cs-CD34+/
α-SMA+ ASCs. In accordance with this hypothesis, we found that
cs-DLK1−/cs-CD34+/CD90+/CD105+dim/α-SMA+/CD45−/CD31− cells
constitute a major cell population in the vascular stroma of sWAT,
which exhibits preadipocyte properties.
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417M.E. Zwierzina et al. / Stem Cell Research 15 (2015) 403–418The endothelium is consistently described as CD31+ (Lin et al.,
2010). The expression of the stem/progenitor cell marker CD34 by en-
dothelial cells in small vessels inWAT is discussed controversial. As pre-
viously shown (Zimmerlin et al., 2010; Lin et al., 2010; Li et al., 2011),
we detected two rings of CD34+ cells, one in the outer adventitial stro-
ma and anothermatchingwith the inner endothelium. In contrast to Lin
et al. (2010), which described all endothelial cells positive for CD34, we
identiﬁed both CD34− and CD34+ vessels. This supports the hypothesis
that well distinguishable subpopulations of CD34− and CD34+ en-
dothelial cells exists (Zimmerlin et al., 2010; Li et al., 2011). We
found that the non-proliferative and non-adipogenic SVF fractions,
cs-DLK1+/cs-CD34− and cs-DLK+/cs-CD34+dim cells, stained positive
for CD31 in FACS analysis and we detected DLK1+ cells in endothelial
layers of small vessels in sWAT. The numbers of DLK1+ cells in the en-
dothelium differed between given vessels. Thus, it is conceivable that
variants of DLK1+ cells play a role in the endothelium while others
exist as ASCs in vascular stroma. Similar to our data, the presence of
DLK1+ cells in adult endothelia was previously shown in adipose tissue
of mice and DLK1+/CD31+ double-positive cells were identiﬁed in the
SVF of miceWAT in the same study (Andersen et al., 2009a). Moreover,
a more recent study showed that DLK1 can inhibit angiogenesis in vas-
cular endothelium (Rodríguez et al., 2012). Thus, a role of a subset of
DLK1+ SVF cells in vascular endothelium of WAT is likely. In lineage
tracing experiments in mice using DLK1 promoter activated expression
of reporter genes tomark adipocyte progenitors, expression of endothe-
lial markers was not detected in the labeled cells (Hudak et al., 2014)
and neither endothelial nor hematopoietic lineage markers labeled
adipocytes (Berry and Rodeheffer, 2013). Thus, it is possible that endo-
thelial cells express DLK1+ transiently during vessel growth and/or
maturation.
The morphology of ASCs and the spatial organization of their niche
surrounding small vessels in human WAT are not precisely known.
We illustrated these cells in the context of small vessels in sWAT by
TEM using DLK1 and CD34 as speciﬁc markers. Our ultrastructure anal-
ysis identiﬁed these ASCs in situ as cells with extremely long processes,
showing a ﬁbroblast-like morphology, similar to adipose progenitors
described in previous studies (Cinti et al., 1984; Hausman et al., 1980),
though DLK1+ and CD34+ cells were distinguishable from other stro-
mal cells. DLK1+ and CD34+ cells preferentially resided in the adventi-
tia of small blood vessels but also at capillaries and less frequently more
peripherally between adipocytes. Our data indicate that the long pro-
cesses of ASCs are very close to other cells in the microenvironment of
WAT as described previously (reviewed in Hausman and Dodson,
2013). In fact, as a distinctive feature peripheral DLK1+ ASCs appear
to be very close or even in direct contact with adipocytes, whichwas es-
pecially veriﬁed by semi-thin sections and EM (Fig. 3D, N, and H). This
spatial orientation of DLK1+ ASCs raises the question whether these
cells mark a population of further differentiating progenitors, which
may form new adipocytes. Moreover, the long processes of DLK1+
ASCs in the adventitia of small blood vessels were detected close to
perivascularmural cells (Fig. 3I, M and I), which also form long process-
es (Berry et al., 2013; Cinti et al., 1984; Hausman and Dodson, 2013).
In adultmice, cells expressing the DLK1 gene exist in both sWAT and
vWAT and DLK1 expressing cells are required for expansion of both
WAT depot types in adult animals (Hudak et al., 2014). Our study indi-
cates for the ﬁrst time that the number of DLK1+ cells in human vWAT
is signiﬁcantly lower than in sWAT depots. Given that DLK1 is a regula-
tor of stem/progenitor cell fate (Andersen et al., 2009b, 2013; FerrónFig. 6. Number of DLK1+ cells in human visceral and subcutaneous WAT depots. Parafﬁn sectio
same donors were stained using anti DLK1 antibodies. Representative photographs are shown.
are marked by arrow heads. (E) Consecutive parafﬁn section of the omental vWAT shown in
inserts. Bar: A–E (50 μm), Inset: A–E (5 μm). (F) Quantiﬁcation of DLK1+ cells in relation to
(lower abdomen, thigh and breast). The mean value and the standard error of the mean (SEM
(two-tailed) for statistical signiﬁcance, deﬁning signiﬁcance differences as P-values b 0.05, n =et al., 2011; Hudak et al., 2014; Mortensen et al., 2012; Wang and Sul,
2009) and that in adipose tissues DLK1 is only found in adipocyte pro-
genitors (Tang et al., 2008; Hudak et al., 2014), our data suggest that
vWAT has a lower capacity to expand and regenerate than sWAT due
to the presence of less DLK1+ progenitor cells.
In conclusion, we detected different DLK1/CD34 subpopulations in
sWAT. Only cs-DLK1−/cs-CD34+/CD90+/CD105+dim/α-SMA+/CD45−/
CD31− cells exhibit proliferative and adipogenic capacity. These ASCs
resemble mural cells with spindle-shaped morphology and long pro-
cesses, they are however predominantly localized in the outer adventi-
tial stromal ring of vessels and around capillaries. Signiﬁcant numbers of
DLK1+ cells are also resident in vascular endothelium. Human vWAT
contains less DLK1+ cells than sWAT.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.scr.2015.08.004.
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